Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target lifted by analysts at Piper Sandler from $70.00 to $80.00 in a research note issued to investors on Monday, The Fly reports. Piper Sandler’s target price points to a potential upside of 1.02% from the company’s previous close. EXAS has been the subject of several […]
Diagnostic and cancer test products provider Exact Sciences Corp. NASDAQ: EXAS saw its shares spike over 17% on its Q1 2023 earnings results. The company is…
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective increased by Bank of America from $80.00 to $88.00 in a report issued on Wednesday morning, The Fly reports. Several other brokerages also recently issued reports on EXAS. Raymond James downgraded shares of Exact Sciences from an outperform rating to a market perform rating in […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target hoisted by BTIG Research from $80.00 to $90.00 in a report released on Wednesday, The Fly reports. A number of other equities research analysts have also weighed in on EXAS. SVB Leerink lifted their target price on shares of Exact Sciences from $70.00 to $75.00 […]
California Public Employees Retirement System lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 328,773 shares of the medical research company’s stock after selling 32,149 […]